# SAMBA EU Femoropopliteal Trial

> **NCT01139177** · NA · UNKNOWN · sponsor: **NovoStent Corporation** · enrollment: 39 (actual)

## Conditions studied

- Peripheral Vascular Disease

## Interventions

- **DEVICE:** Stenting of atherosclerotic lesion(s)

## Key facts

- **NCT ID:** NCT01139177
- **Lead sponsor:** NovoStent Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-04
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2010-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01139177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01139177, "SAMBA EU Femoropopliteal Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01139177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*